The United States Food and Drug Administrations (FDA) has issued a Firm Press Release concerning the voluntary recall of selected Curlin Intravenous Administration Sets, sold and distributed in the United States between December 2011 and May 2012 and manufactured by Moog Medical Devices Group.
The manufacturer found that use of the affected sets may cause desanguination (blood loss), an under-delivery of prescribed medication/fluid, or a potential delay in therapy. Customer complaints have identified three out of 544,900 suspect sets manufactured for the United States. So far, the manufacturer has not received any reports injury or death as a result of this issue.
For details, please refer to FDA website
http://www.fda.gov/Safety/Recalls/ucm305208.htm
If you are in possession of the product, please contact your supplier for necessary actions.
Posted on 24 May 2012